title: The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients.
abstract: We investigated the role of leptin and asymmetric dimethylarginine (ADMA) in uncomplicated hypertension. We also investigated their relationship with insulin resistance and serum levels of several metabolic parameters, including homocysteine, lipoprotein(a) and malondialdehyde (MDA). A total of 34 untreated newly-diagnosed hypertensive patients (seven men and 27 women; mean age, 57.4 +/- 10.1 years) and 38 normotensive healthy subjects (20 men and 18 women; mean age, 55.9 +/- 8.7 years) were studied prospectively. Serum leptin, homocysteine, lipoprotein(a), MDA and insulin resistance (HOMA-IR) were significantly higher in hypertensive patients compared with normotensive subjects. There were no significant differences in ADMA, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 between the two groups. No correlation was found between serum ADMA and leptin levels. Our findings suggest that high serum leptin and homocysteine levels, oxidative stress and insulin resistance may be important risk factors for atherosclerosis among patients with uncomplicated hypertension.
authors.affiliation: Department of Internal Medicine, Diyarbakir State Hospital, Diyarbakir, Turkey. yatamer@dicle.edu.tr
authors.forename: A
authors.initials: A
authors.lastname: Atamer
authors.forename: N
authors.initials: N
authors.lastname: Ilhan
authors.forename: Y
authors.initials: Y
authors.lastname: Kocyigit
authors.forename: G
authors.initials: G
authors.lastname: Toprak
authors.forename: M
authors.initials: M
authors.lastname: Ozbay
authors.forename: Y
authors.initials: Y
authors.lastname: Celik
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D004791:Enzyme Inhibitors / Q000097:blood*; D005260:Female; D006710:Homocysteine / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000097:blood*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology; D018972:Insulin-Like Growth Factor Binding Protein 3; D018969:Insulin-Like Growth Factor Binding Proteins / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D020738:Leptin / Q000097:blood*; D017270:Lipoprotein(a) / Q000097:blood; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D011446:Prospective Studies
chemical_list: D004791:Enzyme Inhibitors; C515497:IGFBP3 protein, human; D007328:Insulin; D018972:Insulin-Like Growth Factor Binding Protein 3; D018969:Insulin-Like Growth Factor Binding Proteins; D020738:Leptin; D017270:Lipoprotein(a); D006710:Homocysteine; C018524:N,N-dimethylarginine; D007334:Insulin-Like Growth Factor I; D001120:Arginine; D019001:Nitric Oxide Synthase